이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Pliant Therapeutics 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Bernard Coulie
최고 경영자
US$11.2m
총 보상
CEO 급여 비율 | 5.5% |
CEO 임기 | 8.3yrs |
CEO 소유권 | 1.0% |
경영진 평균 재임 기간 | 8.3yrs |
이사회 평균 재임 기간 | 6.7yrs |
최근 관리 업데이트
Recent updates
Should Shareholders Reconsider Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) CEO Compensation Package?
Jun 07Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?
Feb 27Is Pliant Therapeutics (NASDAQ:PLRX) Using Debt Sensibly?
Jul 21Health Check: How Prudently Does Pliant Therapeutics (NASDAQ:PLRX) Use Debt?
Mar 13Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?
Sep 10Pliant Therapeutics: Wait For A Better Price To Get In
Aug 20Pliant Therapeutics GAAP EPS of -$0.82 misses by $0.01, revenue of $4.99M
Aug 08Is Pliant Therapeutics (NASDAQ:PLRX) In A Good Position To Deliver On Growth Plans?
Jul 28Pliant's PLN-74809 gets FDA fast track status for liver disease
Jul 21Pliant climbs 48% as mid-stage trial for lung disease therapy meets key goals
Jul 11Pliant: Major Catalyst Expected Beginning Of 2023
Jun 03We're Keeping An Eye On Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Rate
Apr 22Here's Why We're Not Too Worried About Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation
Dec 29We Think Pliant Therapeutics (NASDAQ:PLRX) Can Afford To Drive Business Growth
Sep 07Analysts Have Just Cut Their Pliant Therapeutics, Inc. (NASDAQ:PLRX) Revenue Estimates By 12%
May 17Pliant Therapeutics, Inc. (NASDAQ:PLRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 13Pliant Therapeutics (NASDAQ:PLRX) Is In A Good Position To Deliver On Growth Plans
Mar 22We're Not So Sure You Should Rely on Pliant Therapeutics's (NASDAQ:PLRX) Statutory Earnings
Jan 21Is Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) 6.5% ROE Worse Than Average?
Dec 17Pliant Therapeutics (PLRX) Presents At Piper Sandler 32nd Annual Virtual Healthcare Conference - Slideshow
Dec 02CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$171m |
Dec 31 2023 | US$11m | US$610k | -US$161m |
Sep 30 2023 | n/a | n/a | -US$155m |
Jun 30 2023 | n/a | n/a | -US$144m |
Mar 31 2023 | n/a | n/a | -US$133m |
Dec 31 2022 | US$11m | US$587k | -US$123m |
Sep 30 2022 | n/a | n/a | -US$113m |
Jun 30 2022 | n/a | n/a | -US$109m |
Mar 31 2022 | n/a | n/a | -US$103m |
Dec 31 2021 | US$5m | US$556k | -US$97m |
Sep 30 2021 | n/a | n/a | -US$92m |
Jun 30 2021 | n/a | n/a | -US$81m |
Mar 31 2021 | n/a | n/a | -US$75m |
Dec 31 2020 | US$2m | US$499k | -US$42m |
Sep 30 2020 | n/a | n/a | US$18m |
Jun 30 2020 | n/a | n/a | US$19m |
Mar 31 2020 | n/a | n/a | US$20m |
Dec 31 2019 | US$2m | US$428k | -US$7m |
보상 대 시장: Bernard 의 총 보상 ($USD 11.17M )은 US 시장( $USD 3.43M ).
보상과 수익: 회사가 수익성이 없는 동안 Bernard 의 보상이 증가했습니다.
CEO
Bernard Coulie (57 yo)
8.3yrs
테뉴어
US$11,165,999
보상
Dr. Bernard Coulie, Ph D, M.D. M.B.A. is Director of Septerna, Inc. from February 2024. He serves as Independent Director at SQZ Biotechnologies Company since July 2021 and serves as its Independent Chairm...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | no data | US$11.17m | 1.04% $ 6.8m | |
Chief Financial Officer | 5.5yrs | US$4.44m | 0.30% $ 1.9m | |
General Counsel & Corporate Secretary | 3.7yrs | US$3.32m | 0.048% $ 314.4k | |
Chief Business Officer | 8.3yrs | US$4.36m | 0.30% $ 1.9m | |
Chief Medical Officer | 6.1yrs | US$4.69m | 0.20% $ 1.3m | |
Scientific Founder & Member of Scientific Advisory Board | 9.4yrs | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | 9.4yrs | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | 9.4yrs | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | 9.4yrs | 데이터 없음 | 데이터 없음 | |
Interim Chief Technology Officer | no data | 데이터 없음 | 데이터 없음 | |
Vice President of Investor Relations & Corporate Communications | no data | 데이터 없음 | 데이터 없음 | |
Chief Human Resources Officer | 1.4yrs | 데이터 없음 | 0.0013% $ 8.6k |
8.3yrs
평균 재임 기간
51yo
평균 연령
경험이 풍부한 관리: PLRX 의 관리팀은 노련하고 경험 (평균 재직 기간 8.3 년)입니다.
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
President | 8.3yrs | US$11.17m | 1.04% $ 6.8m | |
Scientific Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Scientific Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Independent Director | 4.5yrs | US$278.71k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Independent Director | 7.9yrs | US$277.21k | 0.058% $ 377.1k | |
Independent Director | 6.8yrs | US$271.96k | 0.049% $ 314.7k | |
Independent Chairman | 6.5yrs | US$296.71k | 0.17% $ 1.1m | |
Independent Director | 5.3yrs | US$277.96k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
6.7yrs
평균 재임 기간
61yo
평균 연령
경험이 풍부한 이사회: PLRX 의 이사회는 경험(평균 재직 기간 6.7 년)으로 간주됩니다.